Autobahn Therapeutics, Inc., a biotechnology company developing restorative treatments for people affected by neuropsychiatric disorders, today announced that management will participate in the ...
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results